Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
Clinical trial NCT02856451 · COMPLETED
Trial details
- NCT number
- NCT02856451
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-09
- Primary completion
- 2020-12-31
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.